Association Analysis of the GSK-3β T–50C Gene Polymorphism with Schizophrenia and Bipolar Disorder
Authors:
- Aleksandra SzczepankiewiczASAleksandra Szczepankiewicz
- Maria SkibinskaMSMaria Skibinska
- Joanna HauserJHJoanna Hauser
- Agnieszka SlopienASAgnieszka Slopien
- Anna Leszczynska-RodziewiczALAnna Leszczynska-Rodziewicz
- Paweł KapelskiPKPaweł Kapelski
- Monika Dmitrzak-WeglarzMDMonika Dmitrzak-Weglarz
- Piotr M. CzerskiPCPiotr M. Czerski
- Janusz K. RybakowskiJRJanusz K. Rybakowski
- 1 February 2006
- journal article
- research article
- Published by S. Karger AG in Neuropsychobiology
- Vol. 53 (1) , 51-56
Abstract
Glycogen synthase kinase-3β (GSK-3β) has been implicated in the pathogenesis of major psychoses. In this paper, the T–50C polymorphism of the GSK-3β gene has been studied in patients with schizophrenia (n = 432), patients with bipolar disorder (n = 416) and in a healthy control group (n = 408). Consensus diagnosis by at least two psychiatrists was made for each patient, according to DSM-IV and ICD-10 criteria, using the Structured Clinical Interview for DSM-IV Axis I Disorders. Genotypes were established by the polymerase chain reaction-restriction fragment length polymorphism method. We have found a trend towards an association for the C allele in the whole group of schizophrenic patients (p = 0.088) and for the heterozygous T/C genotype of bipolar patients (0.095). Significant differences of genotype distribution and allele frequencies of the T–50C polymorphism were found in the female group of bipolar II patients (p = 0.015 for genotypes and p = 0.009 for alleles). In conclusion, this polymorphism may be associated with female gender in bipolar II disorder.Keywords
This publication has 1 reference indexed in Scilit: